InSight

Exit and Growth Strategies for Middle Market Businesses

Author Archive

M&A News In The Healthcare Industry Sector

By Daniel Sirvent | May 08, 2018

The report below provides a good overview of the second Quarter  M&A activity in the Healthcare Industry Sector. M&A activity for North American based target companies in the Healthcare sector for Q1 2018 included 131 closed deals, according to data published by industry data tracker FactSet.
One of the notable transactions of the quarter was announced in March when Akcea Therapeutics, Inc. acquired assets related to the Inotersen and ACKEA-TTR drug licenses from Ionis Pharmaceuticals, Inc. for approximately US$1.7 billion in stock and US$90 million in contingent payout. Akcea Therapeutics, Inc. is a late-stage pharmaceutical company, which engages in the development and commercializing of drugs for the treatment of cardio metabolic diseases caused by lipid disorders.

Spending on major federal health care programs (Medicare, Medicaid, and the Affordable Care Act’s exchange subsidies) has declined as a result 23 percent drop in the cost of Medicare Part D and a 15 percent decline in the projected costs of the Affordable Care Act’s (ACA) coverage through Medicaid and the exchanges.

Read more »


M&A News In The Healthcare Industry Sector

By Daniel Sirvent | Mar 12, 2018

The report below provides a good overview of the first quarter  M&A activity in the Healthcare Industry Sector. M&A activity for North American based target companies in the Healthcare sector for Q4 2017 included 90 closed deals, according to data published by industry data tracker FactSet.

One of the largest transactions of the quarter closed in December when Express Scripts Holding Co. acquired Carecore National Group, LLC, trading as Evicore, from General Atlantic LLC, TA Associates Management LP, MedCare Investment Corp and Ridgemont Partners Management LLC for US$3.6 billion. The acquisition would expand Express Scripts Holding’s services in the pharmaceutical industry. Express Scripts engages in the provision of integrated pharmacy benefit management services. Carecore National Group offers medical benefits management. It currently has approximately 4,000 employees.

Healthcare is still a strong sector for M&A and investment. Of particular interest to investors is cancer therapeutics

Read more »


M&A News In The Healthcare Industry Sector

By Daniel Sirvent | Dec 11, 2017

The report below provides a good overview of the fourth quarter M&A activity in the Healthcare Industry Sector. M&A activity for North American based target companies in the Healthcare sector for Q3 2017 included 183 closed deals, according to data published by industry data tracker FactSet.

National health expenditures are projected to grow at a rate of 5.6% on average per year according to the U.S. Office of Actuary. The country’s aging population is expected to contribute significantly to that spending growth.

Read more »


M&A News for the Healthcare Industry Sector

By Daniel Sirvent | Sep 21, 2017

The report below provides a good overview of the 3rd Quarter M&A activity in the Healthcare Industry Sector. Q2 M&A activity for North American based Healthcare companies included 152 closed deals, according to data published by industry data tracker FactSet Research with an average disclosed transaction value of $142 million.

One of the largest deals of the quarter closed in May when Sawai Pharmaceutical Co. Ltd. acquired Upsher-Smith Laboratories, Inc. from ACOVA, Inc., for US$1.1 Billion in cash. Sawai Pharmaceutical Co. engages in the manufacture and sale of prescription pharmaceutical products that include cardiovascular drugs, antihyperlipidemic agents, diabetes, anticancer drugs and over-the-counter drugs. Upsher-Smith Laboratories manufactures generic pharmaceuticals.

Read more »


BREXIT on Display at the Farnborough International Airshow

By Daniel Sirvent | Jun 30, 2016

Commercial Aerospace “Supercycle”?Front Row Seats for the End of the Commercial Aerospace “Supercycle”?

It goes without saying that Britain’s vote to exit the European Union, or the now familiar BREXIT, has had the media buying ink by the containership as opposed to the proverbial barrel.  Wall Street analysts, corporate forecasters and a fresh wave of armchair economists are all weighing in on what BREXIT will mean for global trade, U.S. interest rates and their retirement portfolios.

The Economics of Commercial Aircraft Orders

While it may appear overly simplistic the principle remains fundamental; a stronger dollar drives dollar-denominated commodity prices lower. The aerospace industry is aware not only of the sharp contraction in crude oil prices since the Thanksgiving Massacre in 2014 (who could miss the relentless media attention), but also of the nearly silent decline in jet fuel prices which has gone virtually unnoticed in the headlines.  As those lower prices have eased a major cost pressure, operators have drawn back the throttle and next generation aircraft and engine acquisitions driving slowdown in new order velocities. Read more »